Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a blood injection make prolapse surgery more durable?

NCT ID NCT05731284

Ongoing Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial tests whether injecting platelet-rich plasma (PRP) into vaginal tissue during prolapse surgery helps improve healing and surgical outcomes. PRP is made from a patient's own blood and contains growth factors that may aid tissue repair. The study compares PRP to a placebo (saline) in 60 women undergoing native tissue prolapse repair, measuring pelvic support and safety over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Platelet-rich plasma (PRP)
What this could lead to
If it works, PRP could become a standard addition to prolapse surgery, helping tissues heal better and reducing the chance of prolapse returning.
What could go wrong
This is a small, early-stage trial with 60 participants, so results may not apply to everyone. PRP is generally safe, but there is a small risk of infection or no benefit over placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PELVIC ORGAN PROLAPSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pelvic organ prolapse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PELVIC ORGAN PROLAPSE

Contacts and locations

Locations

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35249, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.